17α-Hydroxyprogesterone Caproate 250 mg / 500 mg injection
For safe 9 months pregnancy

Trusted therapy
supported by Indian
and International Studies

US FDA approved for the
prevention of recurrent
spontaneous preterm birth

ACOG’s clinical guidance
recognizes as ‘Prediction and
Prevention’ of preterm birth

Dosage form:

Depot Release Injection

Therapeutic Class:

Progestogen for progesterone deficiency during pregnancy

Composition:

17α-Hydroxyprogesterone Caproate – 250mg/ml

Packing Monocarton:

17α-Progestogen for progesterone deficiency during pregnancy

Strengths available:

500mg and 250mg

Dosage form:

Depot Release Injection

Therapeutic Class:

Progestogen for progesterone deficiency during pregnancy

Composition:

17α-Hydroxyprogesterone Caproate – 250mg/ml

Packing Monocarton:

17α-Progestogen for progesterone deficiency during pregnancy

Strengths available:

500mg and 250mg